Evaxion Biotech AS (EVAX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
総資産 | 22.03M | 20.49M | 16.75M | 11.94M | 86.93M | 22.65M | 15.23M | 15.19M |
流動資産合計 | 16.99M | 10.24M | 7.12M | 2.61M | 56.31M | 11.73M | 10.7M | 4.58M |
現金および同等物 | 13.18M | 10.24M | 7.12M | 2.61M | 37.65M | 11.73M | 7.99M | 4.58M |
非流動資産合計 | 9.72M | 10.25M | 9.64M | 9.34M | 59.91M | 10.92M | 8.43M | 10.61M |
負債合計 | 13.72M | 13.91M | 14.22M | 14.68M | 118.82M | 20.05M | 13.98M | 15.11M |
流動負債合計 | 3.76M | 0 | 0 | 0 | 47.77M | 0 | 3.82M | 0 |
非流動負債合計 | 19.78M | 13.91M | 14.22M | 14.68M | 141.1M | 20.05M | 20.17M | 15.11M |
普通株 | 3.89M | 4.22M | 4.39M | 4.42M | 37.9M | 7.96M | 8.24M | 8.73M |
留保所得 | -72.66M | -78.72M | -84.26M | -89.76M | -721.6M | -112.03M | -112.97M | -114.9M |
年末 2023年12月31日 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 11.08M | 11.97M | 40.16M | 22.03M | 86.93M |
流動資産合計 | 10.96M | 10.95M | 34.71M | 16.99M | 56.31M |
現金および同等物 | 9.56M | 5.83M | 32.17M | 13.18M | 37.65M |
非流動資産合計 | 9.36M | 7.04M | 32.44M | 8.3M | -31.89M |
負債合計 | 1.72M | 4.93M | 7.73M | 13.72M | 118.82M |
流動負債合計 | 1.72M | 4.93M | 4.32M | 3.76M | 47.77M |
非流動負債合計 | 0 | 0 | 6.65M | 19.78M | 141.1M |
総資本 | 9.36M | 7.04M | 32.44M | 8.3M | -31.89M |
普通株 | 2.48M | 2.65M | 3.76M | 3.89M | 37.9M |
留保所得 | -15.81M | -27.28M | -50.43M | -72.66M | -721.6M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約